Genomics Tumor Board #5: Precision Therapy in Gynaecologic Cancers

October 25, 2018

The Genomics Tumor Board is a multidisciplinary, educational and interactive national meeting series involving oncologists, geneticists, pathologists, and bioinformaticians striving towards best outcomes for patients.

A short topic of interest on “Precision Therapy in Gynaecologic Cancers” will be presented by Dr David Tan, Consultant Medical Oncologist and Clinician Scientist, National University Cancer Institute, Singapore.


Mount Elizabeth Hospital Orchard, Administrative Conference Room, Level 2.
Physicians Only (CME points accredited)

Date & Time

19 November 2018 (Monday)
5:30 PM to 7:00 PM
Buffet dinner provided

The chairperson of the board is Dr Min-Han Tan, CEO and Medical Director of Lucence Diagnostics. If physicians would like to submit any case for GTB review and/or recommendations, please download, complete the case summary form and submit to [email protected] before 12 November 2018.

On acceptance, cases with genetic profiles will receive further analysis for potential therapies by specialist clinical bioinformaticians and geneticists to present at GTB.

This edition of the Genomics Tumor Board is organized by Lucence Diagnostics and supported by Singapore Society of Oncology and Pfizer.

The Genomics Tumor Board is a Physicians-Only event. If you would like to register for it, kindly fill up the web form on our company page with your details. Thank you.

Need Help?